MedPath

The Clinical Study of Acute Pancreatitis Treated by TongFuSan

Phase 1
Conditions
Acute Pancreatitis
Interventions
Registration Number
NCT02204189
Lead Sponsor
Beijing Friendship Hospital
Brief Summary

The purpose of this study is to determine whether TongFuSan is effective in the treatment of acute pancreatitis with gastrointestinal dysfunction.

Detailed Description

* Patient who is diagnosed with acute pancreatitis(AP) should be included.

* Patients will be divided into two groups as random number table: control group(A) and experimental group(B).

* Group A will be given Mosapride po,and group B will be given TongFusan except for basic treatments of AP.

* Same investigator will write the case report form.

* Investigator will collect the patients' blood in three points: on admission, the third day and the seventh day.

* Otherwise, we need write down patients' clinical manifestation,Traditional Chinese Medicine differentiation, the result of clinical tests.

* When the patient discharge, we will write down the treatment measures, therapeutic effect, length of stay and the costs.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • clinical diagnosis of acute pancreatitis,both mild type and severe type
Exclusion Criteria
  • pregnant or suckling
  • cancer in late time
  • patient near death

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TongFuSanTongFuSanTongFuSan 1g per time, change every day, the duration is seven days
Primary Outcome Measures
NameTimeMethod
the time of first defecationten days
Secondary Outcome Measures
NameTimeMethod
the time of bowel sounds getting back to normalten days

Trial Locations

Locations (1)

Beijing Friendship Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath